These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38200987)

  • 1. Gastrointestinal Manifestations Are Associated with Severe COVID-19 in Children.
    Akkoyun EB; Ashraf B; Hanners N; Kahn J; Most Z
    Healthcare (Basel); 2023 Dec; 12(1):. PubMed ID: 38200987
    [No Abstract]   [Full Text] [Related]  

  • 2. Gastrointestinal manifestations in children with COVID-19 infection: Retrospective tertiary center experience.
    Bitar RR; Alattas B; Azaz A; Rawat D; Miqdady M
    Front Pediatr; 2022; 10():925520. PubMed ID: 36619504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: An Epidemio-Clinical Study.
    Bhandari S; Singh A; Sharma R; Rankawat G; Banerjee S; Gupta V; Dube A; Kakkar S; Sharma S; Keswani P; Agrawal A; Tak A; Nawal CL
    J Assoc Physicians India; 2020 Jun; 68(6):13-19. PubMed ID: 32610873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Gastrointestinal Symptoms, Hepatic Dysfunction, and Outcomes in Hospitalized Patients With COVID-19 Infection: An Early Experience.
    Hasel K; Salim A; Verma S; D'Adamo C; Arrup D; Vinayek R; Dutta SK
    Cureus; 2022 Feb; 14(2):e22152. PubMed ID: 35308711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
    Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
    Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysomnography in patients with obstructive sleep apnea: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(13):1-38. PubMed ID: 23074483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes intensive care unit placement following pediatric adenotonsillectomy.
    Allen DZ; Worobetz N; Lukens J; Sheehan C; Onwuka A; Dopirak RM; Chiang T; Elmaraghy C
    Int J Pediatr Otorhinolaryngol; 2020 Feb; 129():109736. PubMed ID: 31704575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal manifestations in patients with coronavirus disease-2019 (COVID-19): Impact on clinical outcomes.
    Tabesh E; Soheilipour M; Sami R; Mansourian M; Tabesh F; Soltaninejad F; Dehghan M; Nikgoftar N; Gharavinia A; Ghasemi K; Adibi P
    J Res Med Sci; 2022; 27():32. PubMed ID: 35548178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing active pediatric COVID-19 pneumonia from MIS-C.
    Reiff DD; Mannion ML; Samuy N; Scalici P; Cron RQ
    Pediatr Rheumatol Online J; 2021 Feb; 19(1):21. PubMed ID: 33627147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digestive system involvement and clinical outcomes among COVID-19 patients: A retrospective cohort study from Qatar.
    Khan MU; Mushtaq K; Alsoub DH; Iqbal P; Ata F; Chaudhry HS; Iqbal F; Balaraju G; Maslamani MAA; Varughese B; Singh R; Ejji KA; Kaabi SA; Kamel YM; Butt AA
    World J Gastroenterol; 2021 Dec; 27(46):7995-8009. PubMed ID: 35046626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity of SARS-CoV-2 infection in children with inborn errors of immunity (primary immunodeficiencies): a systematic review.
    Alhumaid S; Al Mutared KM; Al Alawi Z; Sabr Z; Alkhars O; Alabdulqader M; Al Dossary N; ALShakhs FM; Majzoub RA; Alalawi YH; Al Noaim K; Alnaim AA; Al Ghamdi MA; Alahmari AA; Albattat SS; Almubarak YS; Al Abdulmohsen EM; Al Shaikh H; Alobaidan ME; Almusallam HH; Alhassan FM; Alamer MA; Al-Hajji JA; Al-Hajji DA; Alkadi AA; Al Mutair A; Rabaan AA
    Allergy Asthma Clin Immunol; 2023 Aug; 19(1):69. PubMed ID: 37559153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK.
    Bloom CI; Drake TM; Docherty AB; Lipworth BJ; Johnston SL; Nguyen-Van-Tam JS; Carson G; Dunning J; Harrison EM; Baillie JK; Semple MG; Cullinan P; Openshaw PJM;
    Lancet Respir Med; 2021 Jul; 9(7):699-711. PubMed ID: 33676593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Gastrointestinal Symptoms and Clinical Outcomes in Hospitalized Coronavirus Disease 2019 Patients: A Single-Center Study from Turkey.
    Dolu S; Bengi G; Avkan-Oğuz V; Tertemiz KC; Gezer NS; Çavuş SA; Alpaydın AÖ; Kuruüzüm Z; Ergan B; Sevinç C; Ömeroğlu Şimsek G; Kılınç O; Örmen M; Sayıner A; Somalı I; Çavdar C; Can G; Demir T; Akarsu M; Savran Y; Soytürk M
    Turk J Gastroenterol; 2022 Nov; 33(11):955-963. PubMed ID: 35946895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.
    Aggarwal A; Shrivastava A; Kumar A; Ali A
    J Assoc Physicians India; 2020 Jul; 68(7):19-26. PubMed ID: 32602676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and outcomes of gastrointestinal symptoms in patients with Corona Virus Disease-19.
    Rogers HK; Choi WW; Gowda N; Nawal S; Gordon B; Onyilofor C; Rogers CM; Yamane D; Borum ML
    Indian J Gastroenterol; 2021 Oct; 40(5):502-511. PubMed ID: 34569014
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.